Strefen Munnsogstafla 8,75 mg Ісландія - ісландська - LYFJASTOFNUN (Icelandic Medicines Agency)

strefen munnsogstafla 8,75 mg

reckitt benckiser healthcare (scandinavia) a/s - flurbiprofenum inn - munnsogstafla - 8,75 mg

Slentrol Європейський Союз - ісландська - EMA (European Medicines Agency)

slentrol

zoetis belgium sa - dirlotapide - Ónæmiskerfi, þó ekki mataræði - hundar - sem aðstoð í stjórnun ofþyngdar og offitu hjá fullorðnum hundum. til að nota sem hluti af heildarþyngdarstjórnunaráætlun sem felur einnig í sér viðeigandi breytingar á mataræði og æfingu.

Spirix Tafla 50 mg Ісландія - ісландська - LYFJASTOFNUN (Icelandic Medicines Agency)

spirix tafla 50 mg

orifarm healthcare a/s - spironolactonum inn - tafla - 50 mg

Spirix Tafla 25 mg Ісландія - ісландська - LYFJASTOFNUN (Icelandic Medicines Agency)

spirix tafla 25 mg

orifarm healthcare a/s - spironolactonum inn - tafla - 25 mg

Livmarli Європейський Союз - ісландська - EMA (European Medicines Agency)

livmarli

mirum pharmaceuticals international b.v. - maralixibat chloride - alagille syndrome - other drugs for bile therapy - livmarli is indicated for the treatment of cholestatic pruritus in patients with alagille syndrome (algs) 2 months of age and older.

Strefen Honung & Citron (Strefen Körsbär & Mint) Munnholsúði, lausn 16,2 mg/ml Ісландія - ісландська - LYFJASTOFNUN (Icelandic Medicines Agency)

strefen honung & citron (strefen körsbär & mint) munnholsúði, lausn 16,2 mg/ml

reckitt benckiser healthcare (scandinavia) a/s - flurbiprofenum inn - munnholsúði, lausn - 16,2 mg/ml

Jemperli Європейський Союз - ісландська - EMA (European Medicines Agency)

jemperli

glaxosmithkline (ireland) limited - dostarlimab - endometrial neoplasms - antineoplastic agents and antibody drug conjugates - jemparli is indicated as monotherapy for the treatment of adult patients with mismatch repair deficient (dmmr)/microsatellite instability-high (msi h) recurrent or advanced endometrial cancer (ec) that has progressed on or following prior treatment with a platinum-containing regimen.

CitraFleet Mixtúruduft, lausn í skammtapoka 10,0 mg/3,5 g/10,97 g Ісландія - ісландська - LYFJASTOFNUN (Icelandic Medicines Agency)

citrafleet mixtúruduft, lausn í skammtapoka 10,0 mg/3,5 g/10,97 g

casen recordati s.l. - natrii picosulfas inn; magnesii oxidum; citric acid - mixtúruduft, lausn í skammtapoka - 10,0 mg/3,5 g/10,97 g

Modiodal Tafla 100 mg Ісландія - ісландська - LYFJASTOFNUN (Icelandic Medicines Agency)

modiodal tafla 100 mg

teva pharma b.v. - modafinilum inn - tafla - 100 mg

Rubraca Європейський Союз - ісландська - EMA (European Medicines Agency)

rubraca

pharmaand gmbh - rucaparib camsylate - Æxli í eggjastokkum - Æxlishemjandi lyf - rubraca is indicated as monotherapy for the maintenance treatment of adult patients with advanced (figo stages iii and iv) high-grade epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in response (complete or partial) following completion of first-line platinum-based chemotherapy. rubraca er ætlað eitt og sér til að viðhalda meðferð fullorðinn sjúklinga með platínu-viðkvæm fallið hágæða þekju blöðrur, eggjaleiðara, eða aðal kviðarholi krabbamein sem eru í svar (heill eða hluta) til að platínu-byggt lyfjameðferð.